In 2023, the share of corresponding/leading authors in scientific publications in immunology and allergy in Canada was below the forecasted values for 2024, indicating growth. From 2024 to 2028, the share is expected to gradually decrease, slipping from 88.21% to 87.34%. Year-on-year analysis reveals a consistent trend of diminishing percentages with a negligible reduction around 0.25% per annum, leading to a five-year CAGR reflecting this minor downtrend.
Future trends to watch for include strategies that recognize collaborative authorship, increased diversity in research leadership, and opportunities for up-and-coming researchers in the discipline which could further influence the balance of author shares.
